nvestigation of plasminogen activator inhibitor-1 4G/5G gen polymorphism in Turkish preeclamptic patients

Basit Öğe Kaydı
dc.contributor.authorErdemoğlu, Mahmut
dc.contributor.authorTosun, Önder
dc.contributor.authorÇöğendez, Ebru
dc.date.accessioned2024-04-24T19:13:08Z
dc.date.available2024-04-24T19:13:08Z
dc.date.issued2021
dc.departmentDicle Üniversitesien_US
dc.description.abstractObjective: The plasminogen activator inhibitor type-1 (PAI-1) is a genetic risk factor that plays a role in the pathogenesis of pre-eclampsia and elevated levels of PAI-1 may lead to an increased risk of thrombosis. At preent, there is considerable controversy about the association between PAI-1 gene polymorphism and preeclampsia. The aim of this study is to investigate whether the pattern of PAI-1 gene polymorphism is a useful marker for preeclampsia or not. Material and Methods: Our study included 83 hypertensive pregnant women (64 preeclamptic women, 12 pregnant women with HELLP syndrome, and 7 eclamptic women) genotyped for PAI-1 gene polymorphism (4G/4G, 4G/5G, and 5G/5G) and 20 healthy pregnant women. The Chi-square analysis was used to evaluate the differences in genotype and allele frequencies between hypertensive pregnant women and healthy controls. Results: The highest PAI-1 gene polymorphism rate was found in the hypertensive group and healthy controls in the 4G/5G allele distribution. No significant difference was determined between the hypertensive group and healthy controls regarding the distribution of PAI-1 4G/4G, 4G/5G, and 5G/5G polymorphic alleles. Conclusion: According to the results obtained from present study, we think that PAI1 gene polymorphism does not contribute to individual differences for the sensitivity of preeclampsia development. However, prospective cohort studies with larger sample sizes are needed to clearly demonstrate the contribution of PAI-1 gene polymorphism to serious pregnancy complications such as preeclampsia.en_US
dc.identifier.endpage66en_US
dc.identifier.issn2757-8062
dc.identifier.issue2en_US
dc.identifier.startpage61en_US
dc.identifier.trdizinid491935
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/491935
dc.identifier.urihttps://hdl.handle.net/11468/28402
dc.identifier.volume52en_US
dc.indekslendigikaynakTR-Dizin
dc.language.isoenen_US
dc.relation.ispartofZeynep Kamil medical journal (Online)
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titlenvestigation of plasminogen activator inhibitor-1 4G/5G gen polymorphism in Turkish preeclamptic patientsen_US
dc.titlenvestigation of plasminogen activator inhibitor-1 4G/5G gen polymorphism in Turkish preeclamptic patients
dc.typeArticleen_US

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu